Stroke Drug Could Help COVID-19 Patients
The research focuses on a drug called tissue plasminogen activator (tPA), which is normally used to quickly dissolve blood clots that cause strokes or heart attacks.
A commenter asks why people don't count death certificates to determine the actual number of deaths above the norm, since we can't trust the reported Covid-19 deaths. Well, people have done this, and it's pretty disturbing. Researchers who did this in Italy found the actual number of excess deaths to be twice the reported rate. In New York and New Jersey, the excess is at least 50%. This can happen because many deaths are not attributed to Covid-19, whether because they are attributed to influenza or pneumonia in the absence of testing, or because the virus can cause symptoms such as stroke and kidney failure, which is jus...
A significant amount of clinical and research interest in thrombosis is focused on large vessels (e.g., stroke, myocardial infarction, deep venous thrombosis, etc.); however, thrombosis is often present in the microcirculation in a variety of significant human diseases, such as disseminated intravascular coagulation, thrombotic microangiopathy, sickle cell disease, and others. Further, microvascular thrombosis has recently been demonstrated in patients with COVID-19, and has been proposed to mediate the pathogenesis of organ injury in this disease.
Identify clinical and radiographic features of venous infarct as a presenting feature of COVID-19 in the young.
We present a retrospective study of 33 patients positive for COVID-19 with neuroimaging-documented ICH and examine anticoagulation use in this population.
We report a case of acute OAO in a young patient with a severe form of Covid-19 infection that was on therapeutic anticoagulation with apixaban for deep venous thrombosis (DVT).
We report the case of a 79-year-old woman, who was admitted for a wake-up stroke due to occlusion of the left middle cerebral artery. She was treated outside the COVID-19-dedicated track of the hospital because she had no concomitant signs or symptoms suggestive of SARS-CoV-2 infection nor recent contact with other infected individuals.
Background: The COVID-19 pandemic has presented unprecedented challenges to healthcare organizations worldwide. A steadily rising number of patients requiring intensive care, a large proportion from racial and ethnic minorities, demands creative solutions to provide high-quality care while ensuring healthcare worker safety in the face of limited resources. Boston Medical Center has been particularly affected due to the underserved patient population we care for and the increased risk of ischemic stroke in patients with COVID-19 infection.
COVID-19 hasn't increased the risk for stroke, but when a stroke occurs it's more likely to be fatal, a new study finds.
Drs Mark Alberts and Jesse Weinberger discuss the mysterious association between COVID-19 and cerebrovascular disease in younger patients.Medscape Neurology
Half of patients hospitalized who have neurological findings for acute stroke could die.